Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor

NCT02471716 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Five Prime Therapeutics, Inc.